Q
QuantaLife
Products and services for the life science research and clinical diagnostic markets
About QuantaLife
QuantaLife, a subsidiary of Bio-Rad Laboratories, specializes in developing advanced multiplex immunoassay systems that enable the detection and quantification of multiple biomarkers, such as proteins, peptides, and nucleic acids, within a single sample. These systems are integral to life science research, clinical diagnostics, and biopharmaceutical processing. QuantaLife's core product, the Bio-Plex Multiplex Immunoassay System, includes instruments, software, calibration and validation tools, and multiplex assay kits, providing a comprehensive solution for high-throughput analysis. The company serves a diverse clientele, including university and research institutions, hospitals, public health and commercial laboratories, as well as biotechnology and pharmaceutical companies. Operating in the life sciences and healthcare markets, QuantaLife generates revenue through the sale of its sophisticated assay systems and related consumables, as well as through service contracts and support.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Oct 2011 | $162M | $162M | Bio-Rad Laboratories | — |
| DEBT✓Debt | Jul 2011 | $3.6M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for QuantaLife is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Paladin Capital Group
Other known investors2 additional known investors
Bio-Rad Laboratories
Mérieux Equity Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about QuantaLife on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See QuantaLife’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






